Clinical Trial Update: Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV [Phase 4]

View source ↗

Summary

Clinical trial update evaluating 24-week vs 48-week treatment durations for chronic hepatitis C genotypes 2 or 3 in people co-infected with HIV, in a Phase 4 st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Snippet

Sponsor: University of Valencia | Conditions: Chronic Hepatitis C, Co-Infection HIV-HCV | Phase 4 | Status: UNKNOWN